Adam Taintor, MD
Dermatology · Ogden, UTNPI 1851563779
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 95.6% of the total across 237 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 28 manufacturers, the largest accounting for just 23.3% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $957, 3.0 times the $318 reported in 2019.
Across 237 payments — averaging $16.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$915
- AbbVie$698
- Johnson & Johnson$397
- Sanofi$243
- Pfizer$224
- Galderma Laboratories, L.p.$220
- plus $1K from 22 others
What the payments were for
- Food & beverage$3,76096%
- Education$1724%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 66 | $915 |
| AbbVie | 46 | $698 |
| Johnson & Johnson | 19 | $397 |
| Sanofi | 14 | $243 |
| Pfizer | 13 | $224 |
| Galderma Laboratories, L.p. | 19 | $220 |
| LEO Pharma Inc. | 8 | $174 |
| Regeneron Healthcare Solutions, Inc. | 7 | $143 |
| E.r. Squibb & Sons, L.L.C. | 8 | $134 |
| Dermavant Sciences, Inc. | 5 | $106 |
| Lilly USA, LLC | 4 | $74 |
| Sanofi-aventis U.S. LLC | 1 | $72 |
| Sun Pharmaceutical Industries Inc. | 4 | $71 |
| Krystal Biotech Inc | 2 | $57 |
| Arcutis Biotherapeutics, Inc. | 3 | $55 |
| Organon | 2 | $45 |
| Almirall LLC | 1 | $41 |
| UCB, Inc. | 2 | $41 |
| Amgen | 2 | $37 |
| Botanix SB Inc | 2 | $35 |
| Genentech USA, Inc. | 2 | $32 |
| Journey Medical Corporation | 1 | $20 |
| Cranial Technologies, Inc | 1 | $20 |
| Sumitomo Pharma America, Inc. | 1 | $19 |
| Merck | 1 | $16 |
| EPI Health, LLC | 1 | $15 |
| Dermira, Inc. | 1 | $15 |
| Incyte Corporation | 1 | $14 |
How this compares
$3,933 in reported general payments places this provider in the 70th percentile of 163 dermatology providers in Utah.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Skyrizi PenRisankizumab-Rzaa | 24 | $548,077 |
| Dupixent SyringeDupilumab | 19 | $85,212 |
| Clindamycin Phosphate | 108 | $5,206 |
| Clobetasol Propionate | 68 | $5,138 |
| Fluocinonide | 132 | $5,103 |
| Ketoconazole | 245 | $3,748 |
| Fluconazole | 55 | $3,043 |
| Doxycycline Monohydrate | 86 | $2,901 |
| Metronidazole | 64 | $2,726 |
| Triamcinolone Acetonide | 231 | $2,683 |
| Econazole Nitrate | 59 | $2,670 |
| Fluorouracil | 23 | $2,243 |
| Betamethasone Valerate | 11 | $1,597 |
| Calcipotriene | 13 | $1,487 |
| Doxycycline Hyclate | 33 | $1,304 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Ogden
- David AllenOgden$5K
- Chad TingeyOgden$5K
- Brian WilliamsMidvale$876K
- Travis JamesProvidence$437K
- Jason HadleyBountiful$294K
- Doug Lass ForshaWest Jordan$213K
- Gerald KruegerSalt Lake City$156K
- Jamie RhoadsMurray$105K
- Kristina DuffinSalt Lake City$89K
- Mark TaylorSalt Lake City$58K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.